Pamlab, Inc.
13
0
0
10
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
7.7%
1 terminated/withdrawn out of 13 trials
90.9%
+4.4% vs industry average
8%
1 trials in Phase 3/4
50%
5 of 10 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
The Use Of L-Methylfolate As A Treatment For Depression
Role: collaborator
L-methylfolate Supplementation to OROS-Methylphenidate Pharmacotherapy in ADHD Adults
Role: collaborator
A Placebo-Controlled Study of Physiologic Effects of L-methylfolate in Schizophrenia Patients
Role: lead
The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN)
Role: lead
Effect of Cerefolin®/CerefolinNAC® on Biomarker Measurements
Role: lead
Deplin® P.L.U.S. Program (Progress Through Learning Understanding & Support)
Role: lead
A Retrospective Analysis of Cerefolin NAC® in Cognitively Impaired Patients
Role: lead
Combination Deplin® and Antidepressant Therapy for a Major Depressive Episode (MDE)- a Retrospective Analysis
Role: lead
Study of Metanx® in Subjects With Type 2 Diabetic Peripheral Neuropathy (DPN)
Role: lead
Study of the Effects of Cerefolin NAC on Inflammation Blood Markers in Older Individuals With Memory Complaints
Role: collaborator
NAC-003 P.L.U.S. Program (Progress Through Learning Understanding & Support)
Role: lead
Néevo®/NéevoDHA® P.L.U.S. Program (Progress Through Learning, Understand & Support)
Role: lead
A Retrospective Analysis of Neevo®/Neevo®DHA Compared to a Standard Prenatal Vitamin in Anemia During Pregnancy
Role: lead
All 13 trials loaded